dehydroepiandrosterone has been researched along with Adrenocortical Carcinoma in 9 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 58-year-old man had adrenocortical carcinoma in the right adrenal gland." | 5.30 | Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma. ( Demura, H; Hirohara, D; Kanazawa, M; Nomura, K; Sawada, T; Seki, M; Takasaki, K, 1999) |
| "To develop a monoclonal antibody against dehydroepiandrosterone (DHEA) and miniaturize it, generating a single-chain antibody variable fragment (scFv) against DHEA as an adrenocortical carcinoma (ACC) marker." | 3.91 | Biomolecular engineering of antidehydroepiandrosterone antibodies: a new perspective in cancer diagnosis and treatment using single-chain antibody variable fragment. ( Alvarenga, LM; Becker-Finco, A; Billiald, P; de Figueiredo, BC; de Moraes, RN; Fogaça, RL; Moura, J; Noiray, M; Noronha, L; Silva, SK; Teixeira, KN; Woiski, TD, 2019) |
| "Adrenocortical carcinoma is a heterogeneous and aggressive cancer that originates from steroidogenic cells within the adrenal cortex." | 1.72 | A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. ( Abate, A; Berruti, A; Bornstein, SR; Bothou, C; Cosentini, D; Hantel, C; Peitzsch, M; Penton, D; Sigala, S; Tiberio, GAM, 2022) |
| "A 58-year-old man had adrenocortical carcinoma in the right adrenal gland." | 1.30 | Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma. ( Demura, H; Hirohara, D; Kanazawa, M; Nomura, K; Sawada, T; Seki, M; Takasaki, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sigala, S | 1 |
| Bothou, C | 1 |
| Penton, D | 1 |
| Abate, A | 1 |
| Peitzsch, M | 1 |
| Cosentini, D | 1 |
| Tiberio, GAM | 1 |
| Bornstein, SR | 1 |
| Berruti, A | 1 |
| Hantel, C | 1 |
| Fogaça, RL | 1 |
| Alvarenga, LM | 1 |
| Woiski, TD | 1 |
| Becker-Finco, A | 1 |
| Teixeira, KN | 1 |
| Silva, SK | 1 |
| de Moraes, RN | 1 |
| Noronha, L | 1 |
| Noiray, M | 1 |
| de Figueiredo, BC | 1 |
| Billiald, P | 1 |
| Moura, J | 1 |
| Ross, IL | 1 |
| Louw, GJ | 1 |
| Velikanova, LI | 1 |
| Shafigullina, ZR | 1 |
| Lisitsin, AA | 1 |
| Vorokhobina, NV | 1 |
| Grigoryan, K | 1 |
| Kukhianidze, EA | 1 |
| Strelnikova, EG | 1 |
| Krivokhizhina, NS | 1 |
| Krasnov, LM | 1 |
| Fedorov, EA | 1 |
| Sablin, IV | 1 |
| Moskvin, AL | 1 |
| Bessonova, EA | 1 |
| Kouyama, R | 1 |
| Hiraishi, K | 1 |
| Sugiyama, T | 1 |
| Izumiyama, H | 1 |
| Yoshimoto, T | 2 |
| Akashi, T | 1 |
| Kihara, K | 1 |
| Homma, K | 2 |
| Shibata, H | 2 |
| Hirata, Y | 2 |
| KELLER, M | 1 |
| Fukai, N | 1 |
| Hirono, Y | 1 |
| Doi, M | 1 |
| Ohtsuka, Y | 1 |
| Sasano, H | 1 |
| Ideyama, Y | 1 |
| Kudoh, M | 1 |
| Tanimoto, K | 1 |
| Susaki, Y | 1 |
| Nanya, T | 1 |
| Nakahara, T | 1 |
| Ishikawa, H | 1 |
| Fujikura, T | 1 |
| Akaza, H | 1 |
| Shikama, H | 1 |
| Seki, M | 1 |
| Nomura, K | 1 |
| Hirohara, D | 1 |
| Kanazawa, M | 1 |
| Sawada, T | 1 |
| Takasaki, K | 1 |
| Demura, H | 1 |
1 review available for dehydroepiandrosterone and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Embryological and molecular development of the adrenal glands.
Topics: Addison Disease; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Dehydroepiandros | 2015 |
8 other studies available for dehydroepiandrosterone and Adrenocortical Carcinoma
| Article | Year |
|---|---|
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldoste | 2022 |
Biomolecular engineering of antidehydroepiandrosterone antibodies: a new perspective in cancer diagnosis and treatment using single-chain antibody variable fragment.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Biomarkers, Tumor; Dehydroepiandrostero | 2019 |
Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adult; Chromatography, H | 2016 |
Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Neoplasms; Adrenocortical | 2011 |
[HORMONE STUDIES IN A CASE OF FEMINIZING ADRENAL CORTEX CARCINOMA].
Topics: 17-Ketosteroids; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Dehydroepiandros | 1963 |
A case of estrogen-secreting adrenocortical carcinoma with subclinical Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Cushing Syndrome; Dehydroepiandrosterone; | 2006 |
YM116, 2-(1H-imidazol-4-ylmethyl)-9H-carbazole, decreases adrenal androgen synthesis by inhibiting C17-20 lyase activity in NCI-H295 human adrenocortical carcinoma cells.
Topics: Adrenal Cortex Hormones; Adrenocortical Carcinoma; Androgens; Androstenedione; Carbazoles; Dehydroep | 1999 |
Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Dehydroepiandro | 1999 |